SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/A555EAED47538F7B9434982BBDF37C5DB692040F886447D0632A4BA5E3D710463D07B9D3BDB91F6B43C31A83CD71C75A>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/A555EAED47538F7B9434982BBDF37C5DB692040F886447D0632A4BA5E3D710463D07B9D3BDB91F6B43C31A83CD71C75A
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/A555EAED47538F7B9434982BBDF37C5DB692040F886447D0632A4BA5E3D710463D07B9D3BDB91F6B43C31A83CD71C75A
http://www.w3.org/2000/01/rdf-schema#comment
"Activating MEK1 exon 3 mutations identified herein and concurrent with V600E/KBRAF do not cause BRAF inhibitor resistance in melanoma."
xsd:string
http://purl.uniprot.org/uniprot/#_7884E3B5FC8EAAC3A51C2C9E89E5987B8A32EF641DFE73315489B4A400FE2DB76BDA39119253A7F875A4F15B93240033
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/A555EAED47538F7B9434982BBDF37C5DB692040F886447D0632A4BA5E3D710463D07B9D3BDB91F6B43C31A83CD71C75A
http://purl.uniprot.org/uniprot/B4DFY5
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/A555EAED47538F7B9434982BBDF37C5DB692040F886447D0632A4BA5E3D710463D07B9D3BDB91F6B43C31A83CD71C75A
http://purl.uniprot.org/uniprot/#_B4DFY5-mappedCitation-22588879
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/A555EAED47538F7B9434982BBDF37C5DB692040F886447D0632A4BA5E3D710463D07B9D3BDB91F6B43C31A83CD71C75A